CMAX - CareMax, Inc. Stock Price, Fair Value and News

3.02USD+0.15 (+5.23%)Delayed as of 26 Apr 2024, 11:55 am ET

Market Summary

USD3.02+0.15

Delayedas of 26 Apr 2024, 11:55 am

5.23%

CMAX Stock Price

View Fullscreen

CMAX RSI Chart

CMAX Valuation

Market Cap

10.7M

Price/Earnings (Trailing)

-0.02

Price/Sales (Trailing)

0.01

EV/EBITDA

0.05

Price/Free Cashflow

-0.17

CMAX Price/Sales (Trailing)

CMAX Profitability

EBT Margin

-91.09%

Return on Equity

-1.1K%

Return on Assets

-109.63%

Free Cashflow Yield

-575.07%

CMAX Fundamentals

CMAX Revenue

Revenue (TTM)

751.1M

Rev. Growth (Yr)

-7.57%

Rev. Growth (Qtr)

-24.78%

CMAX Earnings

Earnings (TTM)

-683.3M

Earnings Growth (Yr)

-4.6K%

Earnings Growth (Qtr)

-351.66%

Breaking Down CMAX Revenue

52 Week Range

3.10

(Low)(High)

Last 7 days

19.2%

Last 30 days

-29.6%

Last 90 days

-76.7%

Trailing 12 Months

-96.0%

How does CMAX drawdown profile look like?

CMAX Financial Health

Current Ratio

0.42

Debt/Equity

0.35

Debt/Cashflow

-2.19

CMAX Investor Care

Shares Dilution (1Y)

23.16%

Diluted EPS (TTM)

-183.31

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	667.2M	719.4M	763.5M	751.1M
2022	404.8M	532.1M	585.2M	631.1M
2021	106.1M	125.3M	205.6M	295.8M
2020	93.8M	97.0M	100.2M	103.4M
2019	0	0	0	90.6M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of CareMax, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 17, 2023	de la torre ralph	acquired	-	-	10,927	-
Nov 17, 2023	oquinn ryan	acquired	-	-	12,123	-
Nov 17, 2023	berg kevin	acquired	-	-	12,123	-
Nov 17, 2023	flynn james e	acquired	-	-	12,123	-
Jun 08, 2023	wirges kevin	acquired	-	-	4,433	evp, treasurer and cfo
Jun 08, 2023	de solo carlos a.	acquired	-	-	14,300	president and ceo
Jun 08, 2023	de solo alberto	acquired	-	-	6,300	evp and coo
May 12, 2023	wirges kevin	acquired	-	-	10,632	evp, treasurer and cfo
May 12, 2023	shulkin david	acquired	-	-	18,585	-
May 12, 2023	rodriguez jose ramon	acquired	-	-	23,381	-

Which funds bought or sold CMAX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	new	-	-	-	-%
Apr 23, 2024	AMALGAMATED BANK	sold off	-100	-3,000	-	-%
Apr 22, 2024	MetLife Investment Management, LLC	sold off	-100	-73,852	-	-%
Apr 18, 2024	Capital Advisors, Ltd. LLC	new	-	1,000	1,000	-%
Apr 16, 2024	Asset Dedication, LLC	added	1,400	-	-	-%
Apr 05, 2024	GAMMA Investing LLC	new	-	400	400	-%
Apr 05, 2024	CWM, LLC	new	-	5,000	5,000	-%
Mar 21, 2024	HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	reduced	-1.48	-2,339,470	704,853	-%
Mar 11, 2024	VANGUARD GROUP INC	added	0.41	-7,042,110	2,174,930	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	114	-95,821	97,354	-%

Are Funds Buying or Selling CMAX?

Are funds buying CMAX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CMAX

No. of Funds

Unveiling CareMax, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	eminence capital, lp	9.3%	10,424,657	SC 13G/A
Feb 12, 2024	morgan stanley	9.5%	10,648,800	SC 13G
Mar 13, 2023	deerfield management company, l.p. (series c)	16.37%	18,691,423	SC 13D/A
Feb 14, 2023	eminence capital, lp	9.4%	10,462,311	SC 13G/A
Feb 14, 2023	athyrium opportunities iii acquisition 2 lp	3.7%	4,167,881	SC 13G/A
Nov 22, 2022	de la torre ralph	16.3%	18,066,223	SC 13D
Nov 07, 2022	deerfield management company, l.p. (series c)	20.72%	18,691,423	SC 13D/A
Jun 02, 2022	deerfield management company, l.p. (series c)	20.72%	18,691,423	SC 13D/A
Feb 15, 2022	deerfield management company, l.p. (series c)	20.79%	18,691,423	SC 13D/A
Feb 14, 2022	eminence capital, lp	9.3%	8,079,616	SC 13G

Recent SEC filings of CareMax, Inc.

View All Filings

Date Filed	Form Type	Document
Mar 18, 2024	NT 10-K	NT 10-K
Mar 18, 2024	8-K	Current Report
Mar 18, 2024	10-K	Annual Report
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 12, 2024	SC 13G	Major Ownership Report
Feb 05, 2024	8-K	Current Report
Jan 29, 2024	8-K	Current Report

Peers (Alternatives to CareMax, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	455.4B	371.6B	0.35%	2.29%	20.35	1.23	14.64%	11.24%
CI	103.7B	195.3B	-0.89%	42.87%	19.3	0.53	8.17%	-20.79%
CVS	84.7B	357.8B	-15.14%	-6.85%	10.14	0.24	10.95%	93.52%
HCA	83.0B	65.0B	-4.22%	12.88%	15.84	1.28	7.86%	-7.11%
CNC	40.5B	154.0B	-2.44%	13.57%	14.98	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-1.82%	53.92%	16.84	0.96	4.57%	23.40%
UHS	11.4B	14.3B	-6.87%	15.65%	15.95	0.8	6.59%	6.24%
MID-CAP
CHE	8.7B	2.3B	-10.00%	2.41%	31.81	3.83	6.06%	9.17%
ACHC	6.8B	2.9B	-4.41%	-0.94%	-312.56	2.31	12.20%	-107.93%
AMN	2.1B	3.8B	-9.00%	-34.66%	10.11	0.56	-27.73%	-52.50%
AMEH	2.0B	1.4B	-7.34%	3.16%	33.37	1.46	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-10.65%	-18.57%	23.8	1.41	11.31%	35.83%
BKD	1.3B	3.0B	6.69%	62.95%	-6.87	0.43	6.74%	20.73%
BEAT	51.9M	-	-9.63%	1.03%	-3.54	-	-	-12.94%
AMS	19.7M	21.3M	20.46%	12.23%	37.05	0.93	8.00%	-62.25%

CareMax, Inc. News

Latest updates

CareMax, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	-24.8%	151,835,500	201,843,000	224,440,000	172,983,000	164,263,000	157,670,000	172,279,000	136,920,000	118,305,500	104,620,000	44,919,000	27,918,000	28,113,518	24,306,000	25,795,000	25,179,964	-
Operating Expenses	106.7%	604,842,000	292,615,000	228,191,000	281,606,000	250,497,500	166,222,000	178,767,000	147,811,000	127,981,500	115,849,000	54,643,000	26,112,000	25,902,692	24,200,000	21,928,000	21,681,617	-
S&GA Expenses	5.1%	3,681,000	3,501,000	3,327,000	3,765,000	3,806,000	2,355,000	2,299,000	3,301,000	2,615,000	1,274,000	775,000	291,000	256,000	311,000	272,000	5,524,251	-
EBITDA Margin	-270.3%	-0.83	-0.22	-0.13	-0.12	-0.04	-0.04	-0.03	0.00	0.04	0.09	0.09	0.10	0.10	-	-	-	-
Interest Expenses	28.3%	11,068,000	8,630,000	8,234,000	6,375,000	5,228,000	3,800,000	2,416,000	1,353,000	2,106,000	1,376,000	437,000	504,000	436,000	-	487,530	327,470	-
Income Taxes	-803.0%	-1,406,000	200,000	177,000	177,000	-20,089,000	181,000	200,000	181,000	159,000	-	-	-	-	-	-	-	-
Earnings Before Taxes	-353.8%	-467,162,000	-102,946,000	-32,199,000	-81,904,000	-9,639,000	-21,872,000	-9,210,000	-16,616,000	-3,396,000	-14,479,000	10,057,000	1,302,000	-	-281,000	3,464,000	-	-
EBT Margin	-206.8%	-0.91	-0.30	-0.20	-0.18	-0.09	-0.09	-0.08	-0.06	-0.02	0.04	0.06	0.07	0.07	-	-	-	-
Net Income	-351.7%	-465,767,000	-103,123,000	-32,376,000	-82,082,000	10,434,500	-22,053,000	-9,381,000	-16,797,000	-3,555,000	-14,479,000	10,057,000	1,302,000	-20,102,346	-315,000	3,464,000	3,171,000	-
Net Income Margin	-235.3%	-0.91	-0.27	-0.18	-0.15	-0.06	-0.09	-0.08	-0.06	-0.02	-0.11	-0.07	-0.15	0.07	0.06	0.06	0.06	0.06
Free Cashflow	140.7%	8,929,000	-21,956,000	-24,465,000	-24,032,000	-30,993,000	-14,382,000	-16,685,000	-13,606,000	-16,078,000	-7,258,000	-6,192,000	1,682,000	-440,879	1,907,000	-204,258	-21,516	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2019Q4
Assets	-41.1%	623	1,058	1,151	1,098	1,171	707	709	649	653	666	633	41.00	39.00	145	85.00	24.00
Current Assets	3.8%	183	177	219	210	197	145	147	93.00	95.00	119	208	16.00	15.00	1.00	0.00	10.00
Cash Equivalents	103.1%	66.00	32.00	55.00	44.00	42.00	53.00	68.00	33.00	48.00	80.00	172	6.00	5.00	10.00	11.00	4.00
Inventory	-	-	-	-	-	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	-	-	0.00
Net PPE	72.1%	48.00	28.00	25.00	23.00	21.00	18.00	17.00	17.00	16.00	16.00	13.00	6.00	5.00	-	-	3.00
Goodwill	-70.0%	157	523	603	603	701	465	465	464	465	452	359	-	10.00	-	-	6.00
Liabilities	5.3%	562	534	526	558	551	238	221	157	148	159	243	33.00	32.00	13.00	-	19.00
Current Liabilities	346.2%	439	98.00	98.00	80.00	77.00	34.00	27.00	28.00	22.00	23.00	62.00	6.00	5.00	0.00	1.00	3.00
Long Term Debt	-92.9%	21.00	303	298	261	231	184	182	110	111	113	114	26.00	26.00	-	-	16.00
LT Debt, Current	-	364	-	-	-	31.00	0.00	0.00	6.00	6.00	6.00	7.00	1.00	1.00	-	-	1.00
LT Debt, Non Current	-92.9%	21.00	303	298	261	231	184	182	110	111	113	114	26.00	26.00	-	-	16.00
Shareholder's Equity	-88.3%	61.00	525	624	540	620	469	488	492	505	506	390	8.00	7.00	11.00	11.00	5.00
Retained Earnings	-182.5%	-720	-255	-152	-119	-37.59	-48.20	-26.14	-16.76	0.00	4.00	18.00	-12.21	-	-1.41	-0.03	-
Additional Paid-In Capital	0.3%	782	780	777	659	657	517	514	509	505	503	372	17.00	-	6.00	0.00	-
Shares Outstanding	0.1%	4.00	4.00	4.00	4.00	3.00	3.00	3.00	3.00	2.00	1.00	1.00	0.00	0.00	0.00	0.00	-
Float	-	-	-	226	-	-	-	223	-	-	-	688	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	181.0%	15,533	-19,183	-21,517	-21,746	-28,405	-12,413	-15,259	-12,139	-15,055	-5,818	-6,355	3,372	-78.88	2,104	-	1,366	-
Share Based Compensation	-20.0%	2,595	3,242	2,464	2,298	2,785	3,611	2,788	1,087	375	966	-	-	-	-	-	-	-
Cashflow From Investing	-138.2%	-6,604	-2,773	-2,948	-2,286	-57,533	-2,076	-1,426	-1,467	-15,268	-89,532	-210,089	-1,690	-	-3,235	-254	-1,604	-
Cashflow From Financing	6404.7%	24,336	-386	34,850	26,627	74,249	-326	52,075	-1,570	-2,212	3,766	382,045	-181	-2,113	1,560	206	2,470	-

CMAX Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Revenue

Total revenue

$ 751,102

$ 631,132

Operating Expenses

External provider costs

572,329

424,182

Cost of care

164,872

126,648

Sales and marketing

14,274

11,761

Corporate, general and administrative

80,684

75,824

Depreciation and amortization

27,787

21,719

Goodwill impairment

547,200

70,000

Acquisition related costs

108

13,165

Total operating expenses

1,407,254

743,297

Operating loss

(656,152)

(112,165)

Nonoperating income (expense)

Interest expense

(54,434)

(20,455)

Change in fair value of derivative warrant liabilities

3,952

4,401

Gain on remeasurement of contingent earnout liabilities

19,916

76,295

Loss on extinguishment of debt

(6,172)

Other income, net

2,507

759

Total nonoperating expenses

(28,059)

54,828

Loss before income tax

(684,211)

(57,337)

Income tax benefit

(863)

(19,542)

Net loss

$ (683,348)

$ (37,796)

Weighted average basic shares outstanding

^[1]

3,727,725

3,026,644

Weighted average diluted shares outstanding

^[1]

3,727,725

3,026,644

Net loss per share

Basic

$ (183.31)

$ (12.49)

Diluted

$ (183.31)

$ (12.49)

Medicare

Revenue

Total revenue

$ 519,834

$ 486,718

Medicaid

Revenue

Total revenue

105,893

96,534

Government Value

Revenue

Total revenue

67,708

6,389

Other Revenue

Revenue

Total revenue

$ 57,667

$ 41,492

[1]	Share amounts have been restated to reflect the 1-for-30 reverse stock split that the Company completed on January 31, 2024.

CMAX Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands

Dec. 31, 2023

Dec. 31, 2022

Current Assets

Cash and cash equivalents

$ 65,528

$ 41,626

Accounts receivable, net

114,754

151,743

Other current assets

3,066

3,968

Total Current Assets

183,348

197,336

Property and equipment, net

47,918

21,006

Operating lease right-of-use assets

109,215

108,937

Goodwill, net

156,841

700,643

Intangible assets, net

101,243

123,585

Deferred debt issuance costs

1,685

Other assets

24,737

17,550

Total Assets

623,301

1,170,743

Current Liabilities

Accounts payable

6,275

7,687

Accrued expenses

16,224

16,854

Risk settlement liabilities

42,602

14,171

Related party liabilities

190

1,777

Related party debt, net

30,277

Current portion of third-party debt, net

364,380

253

Current portion of operating lease liabilities

8,975

5,512

Other current liabilities

165

790

Total Current Liabilities

438,812

77,322

Derivative warrant liabilities

3,974

Long-term debt, net

21,443

230,725

Long-term operating lease liabilities

97,136

96,539

Contingent earnout liability

134,561

Other liabilities

4,443

8,075

Total Liabilities

561,856

551,196

COMMITMENTS AND CONTINGENCIES (NOTE 16)

STOCKHOLDERS' EQUITY

Preferred stock (1,000,000 shares authorized; one share issued and outstanding as of December 31, 2023 and December 31, 2022, respectively)

Class A common stock ($0.0001 par value; 250,000,000 shares authorized; 112,341,960 and 111,332,584 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively)

^[1]

Additional paid-in-capital

782,371

657,126

Accumulated deficit

(720,938)

(37,590)

Total Stockholders' Equity

61,444

619,547

Total Liabilities and Stockholders' Equity

$ 623,301

$ 1,170,743

[1]	Share amounts have been restated to reflect the 1-for-30 reverse stock split that the Company completed on January 31, 2024.

About CareMax, Inc.

CareMax, Inc. provides chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, Tennessee, Texas, and New York. The company is headquartered in Miami, Florida.

CEO	Mr. Carlos A. de Solo
WEBSITE	caremax.com
INDUSTRY	Healthcare Plans
EMPLOYEES	1500

CareMax, Inc. Frequently Asked Questions

What is the ticker symbol for CareMax, Inc.? What does CMAX stand for in stocks?

CMAX is the stock ticker symbol of CareMax, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CareMax, Inc. (CMAX)?

As of Thu Apr 25 2024, market cap of CareMax, Inc. is 10.7 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CMAX stock?

You can check CMAX's fair value in chart for subscribers.

What is the fair value of CMAX stock?

You can check CMAX's fair value in chart for subscribers. The fair value of CareMax, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CareMax, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CMAX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CareMax, Inc. a good stock to buy?

The fair value guage provides a quick view whether CMAX is over valued or under valued. Whether CareMax, Inc. is cheap or expensive depends on the assumptions which impact CareMax, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CMAX.

What is CareMax, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, CMAX's PE ratio (Price to Earnings) is -0.02 and Price to Sales (PS) ratio is 0.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CMAX PE ratio will change depending on the future growth rate expectations of investors.